Letter to the editor in response to Akita et al. 2020

Affiliations

¹ Department of Cardiology, University College London Medical School, 74 Huntley Street, Bloomsbury, London WC1E 6DE, UK.
² University College London Hospitals NHS Foundation Trust, 235 Euston Rd, Bloomsbury, London NW1 2BU, UK.
³ London North West University Healthcare NHS Trust, A404 Watford Rd, Harrow HA1 3UJ, UK.

Comment

George Seligmann et al. Eur Heart J Cardiovasc Pharmacother. 2021.

. 2021 May 23;7(3):e52.

doi: 10.1093/ehjcvp/pvaa112.

¹ Department of Cardiology, University College London Medical School, 74 Huntley Street, Bloomsbury, London WC1E 6DE, UK.
² University College London Hospitals NHS Foundation Trust, 235 Euston Rd, Bloomsbury, London NW1 2BU, UK.
³ London North West University Healthcare NHS Trust, A404 Watford Rd, Harrow HA1 3UJ, UK.

No abstract available

Comment in

Author's reply: Letter to the editor in response to Akita et al. (2020).
Akita K, Inohara T, Kohsaka S, Amano T, Ikari Y, Maekawa Y. Akita K, et al. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e60. doi: 10.1093/ehjcvp/pvaa113. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32991674 No abstract available.

Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan.
Akita K, Inohara T, Yamaji K, Kohsaka S, Numasawa Y, Ishii H, Amano T, Kadota K, Nakamura M, Maekawa Y. Akita K, et al. Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):231-238. doi: 10.1093/ehjcvp/pvz056. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 31593213